Open AccessA Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review
Author(s) -
Takahiro Fuji,
Jun Arai,
Yumi Otoyama,
Yuta Nio,
Ikuya Sugiura,
Yoko Nakajima,
Atsushi Kajiwara,
Yūki Ichikawa,
Shojiro Uozumi,
Yuu Shimozuma,
Manabu Uchikoshi,
Masashi Sakaki,
Hisako Nozawa,
Kenji Momo,
Takeshi Sasaki,
Hitoshi Yoshida
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s383769
Subject(s) - medicine , atezolizumab , bevacizumab , gastroenterology , hepatocellular carcinoma , diarrhea , colitis , prednisolone , chemotherapy , adverse effect , radiology , cancer , nivolumab , immunotherapy